https://www.selleckchem.com/pr....oducts/2-deoxy-d-glu
BACKGROUND Thyroid dysfunction is among the most common adverse effects during anti-PD-1 immunotherapy, and alongside correlations with elevated anti-thyroid antibodies (ATAb), studies have found correlations with survival. However, the exact relations remain to be clarified. We therefore aimed to clarify the relationship between thyroid dysfunction, ATAbs and survival in anti-PD-1 treated cancer patients. METHODS We included 168 patients with non-small-cell lung carcinoma, renal cell carcinoma, and metastatic melanoma treated
Gefällt mir
Kommentar
Teilen
